The invention relates to neutralizing antibodies, and antibody fragments thereof, having {TAIL ~ high potency} in neutralizing hCMV, wherein said antibodies and {HEAD ~ antibody fragments} are specific for one, or a combination of two or more, hCMV gene UL products 
The invention relates to neutralizing antibodies , and antibody fragments thereof , having { TAIL ~ high potency } in neutralizing hCMV , wherein said antibodies and { HEAD ~ antibody fragments } are specific for one , or a combination of two or more , hCMV gene UL products
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH